A randomized trial of daclatasvir in combination with asunaprevir and beclabuvir in patients with chronic hepatitis C virus genotype 4 infection

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of hepatology 2015-05, Vol.62 (5), p.1204-1206
Hauptverfasser:	Hassanein, Tarek, Sims, Karen D, Bennett, Michael, Gitlin, Norman, Lawitz, Eric, Nguyen, Tuan, Webster, Lynn, Younossi, Zobair, Schwartz, Howard, Thuluvath, Paul J, Zhou, Helen, Rege, Bhaskar, McPhee, Fiona, Zhou, Nannan, Wind-Rotolo, Megan, Chung, Ellen, Griffies, Amber, Grasela, Dennis M, Gardiner, David F
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiviral Agents - administration & dosage Antiviral Agents - adverse effects Benzazepines - administration & dosage Benzazepines - adverse effects Drug Monitoring Drug Resistance, Viral Enzyme Inhibitors - administration & dosage Enzyme Inhibitors - adverse effects Female Gastroenterology and Hepatology Hepacivirus - drug effects Hepacivirus - genetics Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology Humans Imidazoles - administration & dosage Imidazoles - adverse effects Indoles - administration & dosage Indoles - adverse effects Isoquinolines - administration & dosage Isoquinolines - adverse effects Male Middle Aged Sulfonamides - administration & dosage Sulfonamides - adverse effects Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!